Research and Markets: Diabetic Complications-Pipeline Insights - Strategically Significant Competitor Information, Analysis, and Insights to Formulate Effective R&D Development Strategies

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/8vffjm/diabetic) has announced the addition of the "Diabetic Complications-Pipeline Insights" report to their offering.

This Diabetic Complications-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Diabetic Complications. This report provides information on the therapeutic development based on the Diabetic Complications dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Diabetic Complications
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Diabetic Complications pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Diabetic Complications and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages

Key Topics Covered:

  • Diabetic Complications Overview
  • Diabetic Complications Pipeline Therapeutics
  • Diabetic Complications Therapeutics under Development by Companies
  • Diabetic Complications Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Diabetic Complications Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Diabetic Complications Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Diabetic Complications Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Diabetic Complications - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Diabetic Complications - Discontinued Products
  • Diabetic Complications - Dormant Products
  • Companies Involved in Therapeutics Development for Diabetic Complications

For more information visit http://www.researchandmarkets.com/research/8vffjm/diabetiC

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals